# Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

> **NCT06924632** · PHASE3 · COMPLETED · sponsor: **Samson Clinical Operations Pty Ltd** · enrollment: 142 (actual)

## Conditions studied

- Androgenetic Alopecia
- Male Pattern Baldness

## Interventions

- **DRUG:** Minoxidil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06924632
- **Lead sponsor:** Samson Clinical Operations Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-14
- **Primary completion:** 2026-05-15
- **Final completion:** 2026-05-15
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06924632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06924632, "Efficacy & Safety of Minoxidil SL Tablets in Men With AGA". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06924632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*